NCT02342379 2020-04-10
TH-302 in Combination With Bevacizumab for Glioblastoma
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
The University of Texas Health Science Center at San Antonio
The University of Texas Health Science Center at San Antonio